作者: Stefan P.J. Dullens , Jogchum Plat , Ronald P. Mensink
DOI: 10.1016/J.NUMECD.2007.05.001
关键词:
摘要: Dyslipidemia leading to coronary heart diseases (CHD) enables venues prevent or treat CHD by other strategies than only lowering serum LDL cholesterol (LDL-C) concentrations, which is currently the most frequently targeted change. Unlike LDL-C, elevated high-density lipoprotein (HDL-C) concentrations may protect against development of as demonstrated in numerous large-scale epidemiological studies. In this review we describe that besides elevating HDL-C increasing alpha-HDL particles, approaches elevate pre-beta HDL particle seems more attractive. Besides infusion apoA-I(Milano), using apoA-I mimetics, delipidation de novo production be a suitable target functionally increase concentrations. Therefore, detailed description molecular pathways underlying synthesis and secretion, completed with an overview known effects pharmacological nutritional compounds on will presented. This knowledge ultimately applied developing dietary intervention consequently lower risk.